HOW TO EXPAND THE ‘SAMPLE SIZE’ OF STUDIES OF DRUG MARKET DISRUPTIONS
✍ Scribed by JONATHAN CAULKINS
- Book ID
- 108598649
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 76 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0965-2140
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
With discovery of an increasing number of candidate genes that may affect inter-individual variability in response to drugs, the design of drug trials that incorporate their study has become relevant. We discuss the determination of sample size for such studies when the number of tests to perform is
## Abstract Bioequivalence studies of drugs which are not systematically available must rely on the measure of the pharmacological response. Detection of a difference between two such preparations is often hampered by the need to include an elevated number of subjects. The number of subjects can be
## Abstract Genome‐wide association (GWA) studies have proved extremely successful in identifying novel genetic loci contributing effects to complex human diseases. In doing so, they have highlighted the fact that many potential loci of modest effect remain undetected, partly due to the need for sa